Abstract:Background Cysteine protease cathepsins are important in extracellular matrix protein degradation, cell apoptosis, and angiogenesis. Mice lacking cathepsins are protected from tumor progression in several animal models, suggesting that the regulation of cathepsin activities controls the growth of various malignant tumors. Methods and Results We tested the role of cathepsins using a mouse model of multistage epithelial carcinogenesis, in which the human keratin-14 promoter/enhancer drove the expression of human papillomavirus type 16 (HPV16) early region E6/E7 transgenes. During the progression of premalignant dysplasia, we observed increased expression of cysteine protease cathepsin S, but concomitantly reduced expression of cathepsin endogenous inhibitor cystatin C in the skin tissue extract. Absence of cystatin C in these transgenic mice resulted in more progression of dysplasia to carcinoma in situ on the face, ear, chest, and tail. Chest and ear skin extract real time PCR and immunoblot analysis, mouse serum sample ELISA, tissue immunohistological analysis, and tissue extract-mediated in vitro elastinolysis and collagenolysis assays demonstrated that cystatin C deficiency significantly increased cathepsin expression and activity. In skin from both the chest and ear, we found that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation. From the same tissue preparations, we detected significantly higher levels of pro-angiogenic laminin 5-derived γ2 peptides and concurrently increased neovascularization in cystatin C-deficient mice, compared to those from wild-type control mice. Conclusion Enhanced cathepsin expression and activity in cystatin C-deficient mice contributed to the progression of dysplasia by altering premalignant tissue epithelial proliferation, apoptosis, and neovascularization.

REGγ is Critical for Skin Carcinogenesis by Modulating the Wnt/β-catenin Pathway

REGγ Accelerates Melanoma Formation by Regulating Wnt/β‐catenin Signalling Pathway

Lgr4 is Crucial for Skin Carcinogenesis by Regulating MEK/ERK and Wnt/β-catenin Signaling Pathways

P2RY6 Has a Critical Role in Mouse Skin Carcinogenesis by Regulating the YAP and β-Catenin Signaling Pathways.

REGγ Mediated Regulation of P21waf/cip1, P16ink4a and P14arf/p19arf in Vivo

Tumor Promoter TPA Activates Wnt/β-catenin Signaling in a Casein Kinase 1-Dependent Manner.

REGγ Mediated Regulation of p21 Waf/Cip1 , p16 INK4a and p14 ARF /p19 ARF in Vivo

The REGγ-proteasome Forms a Regulatory Circuit with IκBɛ and NFκB in Experimental Colitis

REGγ modulates p53 activity by regulating its cellular localization

The Reg Gamma-Proteasome Forms A Regulatory Circuit With I Kappa B Epsilon And Nf Kappa B In Experimental Colitis

Regulation of c-Myc protein stability by proteasome activator REG γ

Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice.

REGgamma modulates p53 activity by regulating its cellular localization.

The REG g-proteasome forms a regulatory circuit with I k B e and NF k B in experimental colitis

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IκB-α/NF-κB

Targeting Expression of a Dominant-Negative Retinoic Acid Receptor Mutant in the Epidermis of Transgenic Mice Results in Loss of Barrier Function.

Suppressive Function of RKTG on Chemical Carcinogen-Induced Skin Carcinogenesis in Mouse.

Differential Regulation of the REGγ–proteasome Pathway by P53/tgf-Β Signalling and Mutant P53 in Cancer Cells

REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.

REGγ, a proteasome activator and beyond?